These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1659435)

  • 21. Pharmacoeconomic issues of sedation, analgesia, and neuromuscular blockade in critical care.
    Armstrong DK; Crisp CB
    New Horiz; 1994 Feb; 2(1):85-93. PubMed ID: 7922434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacology of neuromuscular blockade: interactions and implications for concurrent drug therapies.
    Dickens MD
    Crit Care Nurs Q; 1995 Aug; 18(2):1-12. PubMed ID: 7621092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring of neuromuscular function.
    Ali HH; Savarese JJ
    Anesthesiology; 1976 Aug; 45(2):216-49. PubMed ID: 180849
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of pharmacologically induced neuromuscular blockade using peripheral nerve stimulation.
    Loyola R; Dreher HM
    Dimens Crit Care Nurs; 2003; 22(4):157-64; quiz 165-6. PubMed ID: 12893991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent paralysis in critically ill patients after the use of neuromuscular blocking agents.
    Hoyt JW
    New Horiz; 1994 Feb; 2(1):48-55. PubMed ID: 7922429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient.
    Murray MJ; Cowen J; DeBlock H; Erstad B; Gray AW; Tescher AN; McGee WT; Prielipp RC; Susla G; Jacobi J; Nasraway SA; Lumb PD;
    Crit Care Med; 2002 Jan; 30(1):142-56. PubMed ID: 11902255
    [No Abstract]   [Full Text] [Related]  

  • 27. The decision to use succinylcholine for critically ill patients should not be based on duration of time in the intensive care unit alone.
    Bittner EA; Martyn JAJ; Gronert GA
    Anesth Analg; 2013 May; 116(5):1182. PubMed ID: 23606469
    [No Abstract]   [Full Text] [Related]  

  • 28. Monitoring neuromuscular function.
    Monti EJ; Kerr ME; Bender C
    J Neurosci Nurs; 1995 Aug; 27(4):252-7. PubMed ID: 7499932
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical uses and controversies of neuromuscular blocking agents in infants and children.
    Martin LD; Bratton SL; O'Rourke PP
    Crit Care Med; 1999 Jul; 27(7):1358-68. PubMed ID: 10446832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a policy for patients receiving neuromuscular blocking agents.
    Earl G; McMahon MB; Bartley M; Mancini W; Becker S
    J Trauma Nurs; 1997; 4(3):76-81. PubMed ID: 9407819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuromuscular blocking agents in the management of respiratory failure. Indications and treatment guidelines.
    Sapirstein A; Hurford WE
    Crit Care Clin; 1994 Oct; 10(4):831-43. PubMed ID: 8000929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An algorithm for train-of-four monitoring in patients receiving continuous neuromuscular blocking agents.
    Jones SK
    Dimens Crit Care Nurs; 2003; 22(2):50-7; quiz 58-9. PubMed ID: 12649615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sedation and pain control in the critically ill patient maintained on continuous neuromuscular blockade.
    Esch NJ
    Crit Care Nurs Q; 1995 Aug; 18(2):85-95. PubMed ID: 7621098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromuscular blockade.
    Neigh JL
    Surg Clin North Am; 1975 Aug; 55(4):837-50. PubMed ID: 241125
    [No Abstract]   [Full Text] [Related]  

  • 35. Neuromuscular blocking agents: a review.
    Comfort M
    AANA J; 1981 Apr; 49(2):159-65. PubMed ID: 6261512
    [No Abstract]   [Full Text] [Related]  

  • 36. Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: an executive summary. Society of Critical Care Medicine.
    Shapiro BA; Warren J; Egol AB; Greenbaum DM; Jacobi J; Nasraway SA; Schein RM; Spevetz A; Stone JR
    Crit Care Med; 1995 Sep; 23(9):1601-5. PubMed ID: 7664564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of neuromuscular blockers in the critical patient].
    Sandiumenge A; Anglés R; Martínez-Melgar JL; Torrado H;
    Med Intensiva; 2008 Feb; 32 Spec No. 1():69-76. PubMed ID: 18405540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of neuromuscular blocking agents in the intensive care unit.
    Hanson CW
    Crit Care Clin; 1994 Oct; 10(4):779-97. PubMed ID: 8000926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selecting neuromuscular-blocking drugs for elderly patients.
    Cope TM; Hunter JM
    Drugs Aging; 2003; 20(2):125-40. PubMed ID: 12534313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient: 2016 update-executive summary.
    Murray MJ; DeBlock HF; Erstad BL; Gray AW; Jacobi J; Jordan CJ; McGee WT; McManus C; Meade MO; Nix SA; Patterson AJ; Sands K; Pino RM; Tescher AN; Arbour R; Rochwerg B; Murray CF; Mehta S
    Am J Health Syst Pharm; 2017 Jan; 74(2):76-78. PubMed ID: 28069681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.